RTIL 13
Code | Size | Price |
---|
TAR-T38407-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
RTIL 13 is a potent inhibitor of dynamin GTPase , with an IC 50 of 2.3 μM for dynamin I GTPase . RTIL 13 also targets pleckstrin homology lipid binding domain . RTIL 13 can inhibit receptor-mediated and synaptic vesicle endocytosis, with IC 50 s of 9.3 μM and 7.1 μM, respectively.
CAS:
1009376-10-6
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Zhang J, et, al. From Spanish fly to room-temperature ionic liquids (RTILs): synthesis, thermal stability and inhibition of dynamin 1 GTPase by a novel class of RTILs. New Journal of Chemistry. 2008 Jan; 32(1): 1-180.
Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a? with Children's Medical Research Institute and University of Newcastle. Tuesday, December 28, 2021.